2017-03-09 14:12:51 UTC

AGA Postgraduate Course: Early Bird Deadline is March 22

March 13, 2017

After Wednesday, registration rates will go up by $75. AGA members receive deep discounts .

Next Wednesday, March 22, is the last day for early bird registration for the AGA Postgraduate Course: The Full Scope of GI Advances. After Wednesday, registration rates will go up by $75 for the course.

Attendees at this year's postgraduate course will benefit from new features implemented by course director Suzanne Rose, MD, MSEd, AGAF, and co-directors David Cohen, MD, PhD, AGAF, and Uma Mahadevan, MD, AGAF. The course directors have asked each speaker to give real-time pre- and post-tests, and each presentation will include one technological or therapeutic advance that can be applied to practice.

With general sessions focusing on hot topics, IBD, upper GI tract, the liver, pancreatobiliary disease and the colon, attendees will leave the course with new ideas that will guide their clinical decisions all year long. Attendees will also participate in smaller, interactive breakout sessions that delve deeper into specific clinical topics and provide direct access to internationally renowned faculty.

The course will be held May 6 and 7 during Digestive Disease Week® (May 6–9). Register today to attend at the discounted rate and earn up to 12 AMA PRA Category 1 Credits™ and 12 American Board of Internal Medicine maintenance of certification points.

 

More on CME Credit

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Nov. 14, 2017

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.